Skip to main content
Top
Published in: Surgical Endoscopy 1/2006

01-01-2006

Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device

Authors: B. J. Dunkin, J. Martinez, P. A. Bejarano, C. D. Smith, K. Chang, A. S. Livingstone, W. S. Melvin

Published in: Surgical Endoscopy | Issue 1/2006

Login to get access

Abstract

Background

The goal of this study was to determine the optimal treatment parameters for the ablation of human esophageal epithelium using a balloon-based bipolar radiofrequency (RF) energy electrode.

Methods

Immediately prior to esophagectomy, subjects underwent esophagoscopy and ablation of two separate, 3-cm long, circumferential segments of non-tumor-bearing esophageal epithelium using a balloon-based bipolar RF energy electrode (BARRX Medical, Inc., Sunnyvale, CA, USA). Subjects were randomized to one of three energy density groups: 8, 10, or 12 J/cm2. RF energy was applied one time (1×) proximally and two times (2×) distally. Following resection, sections from each ablation zone were evaluated using H&E and diaphorase. Histological endpoints were complete epithelial ablation (yes/no), maximum ablation depth, and residual ablation thickness after tissue slough. Outcomes were compared according to energy density group and 1× vs 2× treatment.

Results

Thirteen male subjects (age, 49–85 years) with esophageal adenocarcinoma underwent the ablation procedure followed by total esophagectomy. Complete epithelial removal occurred in the following zones: 10 J/cm2 (2×) and 12 J/cm2 (1× and 2×). The maximum depth of injury was the muscularis mucosae: 10 and 12 J/cm2 (both 2×). A second treatment (2×) did not significantly increase the depth of injury. Maximum thickness of residual ablation after tissue slough was only 35 μm.

Conclusions

Complete removal of the esophageal epithelium without injury to the submucosa or muscularis propria is possible using this balloon-based RF electrode at 10 J/cm2 (2×) or 12 J/cm2 (1× or 2×). A second application (2×) does not significantly increase ablation depth. These data have been used to select the appropriate settings for treating intestinal metaplasia in trials currently under way.
Literature
1.
go back to reference Ackroyd R, Brown NJ, Stephenson TJ, Stoddard CJ, Reed MWR (1999) Ablation treatment for Barrett oesophagus: what depth of tissue destruction is needed? J Clin Pathol 52: 509–512PubMedCrossRef Ackroyd R, Brown NJ, Stephenson TJ, Stoddard CJ, Reed MWR (1999) Ablation treatment for Barrett oesophagus: what depth of tissue destruction is needed? J Clin Pathol 52: 509–512PubMedCrossRef
2.
3.
go back to reference Ganz RA, Utley DS, Stern RA, Jackson J, Batts KP, Termin P (2004) Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus. Gastrointest Endosc 60: 1002–1010PubMedCrossRef Ganz RA, Utley DS, Stern RA, Jackson J, Batts KP, Termin P (2004) Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus. Gastrointest Endosc 60: 1002–1010PubMedCrossRef
4.
go back to reference Ganz RA, Zelickson B, Stern R, Termin P, Coles C (2003) A method of endoscopic esophageal mucosal ablation using a novel RF energy balloon catheter (BARRx): response characteristics. Gastrointest Endosc 57: M1767 Ganz RA, Zelickson B, Stern R, Termin P, Coles C (2003) A method of endoscopic esophageal mucosal ablation using a novel RF energy balloon catheter (BARRx): response characteristics. Gastrointest Endosc 57: M1767
5.
go back to reference Gerson LB, Shetler K, Triadafilopoulos G (2002) Prevalence of Barrett’s esophagus in asymptomatic individuals. Gastroenterology 123: 636–639CrossRef Gerson LB, Shetler K, Triadafilopoulos G (2002) Prevalence of Barrett’s esophagus in asymptomatic individuals. Gastroenterology 123: 636–639CrossRef
6.
go back to reference Reid BJ (1991) Barrett’s esophagus and adenocarcinoma. Gastroenterol Clin North Am 20: 817–834PubMed Reid BJ (1991) Barrett’s esophagus and adenocarcinoma. Gastroenterol Clin North Am 20: 817–834PubMed
7.
go back to reference Rex DK, Cummings OW, Shaw M, et al (2003) Screening for Barrett’s esophagus in colonoscopy patients with and without heartburn. Gastroenterology 125: 1670–1677PubMedCrossRef Rex DK, Cummings OW, Shaw M, et al (2003) Screening for Barrett’s esophagus in colonoscopy patients with and without heartburn. Gastroenterology 125: 1670–1677PubMedCrossRef
8.
go back to reference Sampliner RE (2002) Updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus. Am J Gastroenterol 97: 1888–1895PubMedCrossRef Sampliner RE (2002) Updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus. Am J Gastroenterol 97: 1888–1895PubMedCrossRef
10.
go back to reference Winawer SJ, Zauber AG, Ho MN, et al (1993) Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 329: 1977–1981PubMedCrossRef Winawer SJ, Zauber AG, Ho MN, et al (1993) Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 329: 1977–1981PubMedCrossRef
Metadata
Title
Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device
Authors
B. J. Dunkin
J. Martinez
P. A. Bejarano
C. D. Smith
K. Chang
A. S. Livingstone
W. S. Melvin
Publication date
01-01-2006
Publisher
Springer-Verlag
Published in
Surgical Endoscopy / Issue 1/2006
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-005-8279-9

Other articles of this Issue 1/2006

Surgical Endoscopy 1/2006 Go to the issue